| abstract |
The present invention is directed to compounds of pharmaceutical interest. More particularly, it is directed to the compounds of formula (I), the methods for obtaining them, the intermediates of their synthesis and the procedures for obtaining them. The compounds of formula (I) have a certain affinity for the vitamin D receptor, are active in an order similar to 1,25α-dihydroxyvitamin D3 (1,25D), with the advantage of presenting a minor or no hypercalcemia. |